Inactive Instrument

Isodiol International Inc Share Price Other OTC

Equities

CA46500L1013

Pharmaceuticals

Sales 2018 1.91Cr 159.77Cr Sales 2019 2.22Cr 185.74Cr Capitalization 5Cr 417.08Cr
Net income 2018 -3.6Cr -300.55Cr Net income 2019 -13Cr -1.05TCr EV / Sales 2018 12.6 x
Net cash position 2018 1.55Cr 129.82Cr Net Debt 2019 52.22L 44Cr EV / Sales 2019 2.48 x
P/E ratio 2018
-4.94 x
P/E ratio 2019
-0.37 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 24/17/24
Director/Board Member - 30/18/30
Corporate Officer/Principal - 14/19/14
Members of the board TitleAgeSince
Chief Executive Officer - 24/17/24
Director/Board Member - 30/18/30
Director/Board Member - 21/18/21
More insiders
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nano-technology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
More about the company